Acute Myeloid Leukemia Market

Acute myeloid leukemia (AML) is a type of blood cancer. Learn more about AML causes, symptoms, diagnosis, and treatment.

Acute Myeloid Leukemia Market contains market size and forecasts of Acute Myeloid Leukemia in Global, including the following market information:

• Global Acute Myeloid Leukemia Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Acute Myeloid Leukemia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Acute Myeloid Leukemia include GSK, Novartis, Roche, Bristol-Myers Squibb, Celgene, Clavis Pharma ASA, Daiichi Sankyo, Eisai and Teva and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Acute Myeloid Leukemia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Acute Myeloid Leukemia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Acute Myeloid Leukemia Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Targeted Therapy

Global Acute Myeloid Leukemia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Acute Myeloid Leukemia Market Segment Percentages, by Application, 2021 (%)

• Adults
• Children

Global Acute Myeloid Leukemia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Acute Myeloid Leukemia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Acute Myeloid Leukemia revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Acute Myeloid Leukemia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Novartis
• Roche
• Bristol-Myers Squibb
• Celgene
• Clavis Pharma ASA
• Daiichi Sankyo
• Eisai
• Teva
• Sunesis Pharmaceuticals